RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.93B
AUM Growth
+$243M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$95M
2
+$77.3M
3
+$72.9M
4
PCVX icon
Vaxcyte
PCVX
+$61.2M
5
ACRV icon
Acrivon Therapeutics
ACRV
+$55.4M

Top Sells

1
+$180M
2
+$112M
3
+$74.6M
4
RLMD icon
Relmada Therapeutics
RLMD
+$74M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.5M

Sector Composition

1 Healthcare 99.36%
2 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
– –
-896,724
77
– –
-2,246,503
78
– –
-1,710,265
79
– –
-764,653
80
– –
-717,618
81
– –
-2,000,000
82
– –
-34,176
83
– –
-307,894
84
– –
-418
85
– –
-383,540
86
– –
-1,578,820
87
– –
-1,954,698
88
– –
-1,250,000
89
– –
-750,000
90
– –
-9,011,651
1 2 3
4